An international clinical trial to evaluate new therapies to improve survival of children with relapsed acute lymphoblastic leukaemia

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1024232

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Children who relapse with childhood leukaemia have only a 50% chance of being alive after 5 years. We will participate in a new international trial involving most European and all Australian and New Zealand childhood oncology centres, to test the effectiveness of promising new treatments and to perform biological studies which should enable doctors in future to pick the best treatment for each of these patients.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2018

Funding Scheme: Project Grants

Funding Amount: $1,567,500.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Chemotherapy

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

NOD/SCID mouse model | acute lymphoblastic leukaemia (ALL) | clinical trial | minimal residual disease | molecular diagnostics | randomised controlled trial (RCT) | survival analysis | therapeutic drug monitoring | translational research

Related Links